World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
27301
World Ranking
16994
National Ranking
1544

Overview

Walter M Gregory is affiliated with the University of Leeds in the United Kingdom. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a substantial focus on Hematology, Molecular Biology, and Oncology as key subfields of study.

The scientist's work addresses several specialized topics, including:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • Bone Health and Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Chronic Myeloid Leukemia Treatments

Walter M Gregory has contributed extensively to scholarly literature, with numerous publications in prominent medical and scientific journals. Frequent venues for their work include:

  • Blood
  • British Journal of Haematology
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Haematologica

Among their recent papers are:

  • "Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials," 2020, Blood
  • "Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial," 2023, The Lancet Oncology
  • "Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk," 2022, Journal of Clinical Oncology
  • "Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma," 2020, British Journal of Haematology
  • "SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection," 2020, European Respiratory Journal

Walter M Gregory has collaborated frequently with a core group of researchers, including:

  • David A. Cairns
  • Mark T. Drayson
  • Roger G. Owen
  • Martin Kaiser
  • Faith E. Davies

Best Publications

  • Who should measure quality of life, the doctor or the patient?

    M. L. Slevin;H. Plant;D. Lynch;J. Drinkwater

  • Mental health of hospital consultants: the effects of stress and satisfaction at work

    A J Ramirez;J Graham;M A Richards;A Cull

  • Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

    M L Slevin;L Stubbs;H J Plant;P Wilson

  • Burnout and psychiatric disorder among cancer clinicians.

    Amanda-Jane Ramirez;Jill Graham;Michael Richards;A Cull

  • First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

    Gareth J Morgan;Faith E Davies;Walter M Gregory;Kim Cocks

  • Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

    Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison

  • Follicular lymphoma: prognostic factors for response and survival.

    C J Gallagher;W M Gregory;A E Jones;A G Stansfeld

  • Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

    Richard J. Kelly;Anita Hill;Louise M. Arnold;Gemma L. Brooksbank

  • A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

    M L Slevin;P I Clark;S P Joel;S Malik

  • Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.

    Nikhil C. Munshi;Herve Avet-Loiseau;Andy C. Rawstron;Roger G. Owen

  • Breast-Cancer Adjuvant Therapy with Zoledronic Acid

    Robert E. Coleman;Helen Marshall;David Cameron;David Dodwell

  • Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

    Andy C. Rawstron;J. Anthony Child;Ruth M. de Tute;Faith E. Davies

  • Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.

    W M Gregory;M A Richards;J S Malpas

  • A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

    Brian A. Walker;Paola E. Leone;Laura Chiecchio;Nicholas J. Dickens

  • The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

    Gareth J. Morgan;Walter M. Gregory;Faith E. Davies;Sue E. Bell

  • Cyclin D1 and prognosis in human breast cancer

    Cheryl Gillett;Paul Smith;Walter Gregory;Michael Richards

  • The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

    P. A. Hall;M. A. Richards;W. M. Gregory;A. J. D'Ardenne

  • Prognostic Factors for the Progression of Keratoconus

    Stephen J. Tuft;Lalitha C. Moodaley;Walter M. Gregory;Charles R. Davison

  • A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

    K D Boyd;F M Ross;L Chiecchio;G P Dagrada

  • Failure to Preserve Fertility in Patients With Hodgkin's Disease

    J Waxman;R Ahmed;David B Smith;P Wrigley

Frequent Co-Authors

Gareth J. Morgan
Gareth J. Morgan Boston University
Faith E. Davies
Faith E. Davies New York University Langone Medical Center
Graham Jackson
Graham Jackson University of Newcastle Australia
Mark T. Drayson
Mark T. Drayson University of Birmingham
Brian A Walker
Brian A Walker Indiana University – Purdue University Indianapolis
Nigel H. Russell
Nigel H. Russell University of Nottingham
Andy C. Rawstron
Andy C. Rawstron Leeds Teaching Hospitals NHS Trust
Robert E. Coleman
Robert E. Coleman University of Sheffield
Julia Brown
Julia Brown University of Leeds
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career doesn’t always mean becoming a physician. There are multiple pathways and online degree options that cater to roles in healthcare, each with unique responsibilities and benefits.

For those interested in healthcare management rather than direct clinical care, a health information management degree online offers a flexible entry point into administrating medical records and health systems. Another in-demand field is medical billing and coding; a low cost medical coding and billing online program can prepare you for these technical, detail-driven careers without high tuition costs.

Nursing is also a highly sought-after career path, with many online options available for various levels. Those seeking advanced practice can explore cheap np programs to become a nurse practitioner, while the cheapest online bsn programs provide a more affordable way to earn a Bachelor of Science in Nursing.

These online programs offer accessible routes to rewarding healthcare careers, accommodating different interests, skill sets, and budgets.

Best Scientists Citing Walter M Gregory

Trending Scientists

Recently Published Articles